Security
ZOETIS INC. · ZTS
ZTSNYSECommon stockCurrentCIK 1555280Updated Oct 14, 2026
ZTS price & chart
Loading TradingView…
NYSE:ZTS on TradingView ↗About the company
Zoetis is the world’s leading animal health company, driven by a singular purpose: to nurture our world and humankind by advancing care for animals. With a legacy of nearly 75 years, Zoetis continues to pioneer ways to predict, prevent, detect, and treat animal illness, supporting veterinarians, livestock producers, and pet owners in over 100 countries. We integrate deep scientific expertise, data-driven R&D, advanced manufacturing, and commercial excellence to deliver meaningful innovation across medicines, vaccines, diagnostics, biopharmaceuticals, and digital solutions. Guided by our vision to be the most trusted and valued animal health company, Zoetis is committed to setting new standards for the future of animal care through innovation, customer obsession, and purpose-driven colleagues. To learn more, visit Zoetis.com.
In the news
ZTS Shareholder Alert: Zoetis Inc. Securities Class Action Lawsuit - Investors With Losses May Contact The Gross Law Firm ↗
ZTS Investors Have Opportunity to Lead Zoetis Inc. Securities Fraud Lawsuit with the Schall Law Firm ↗
SueWallSt Reminds Shareholders of a Lead Plaintiff Deadline of July 27, 2026 in Zoetis Inc. Lawsuit - ZTS ↗
Seeking Alpha
10 Dividend Growth Stocks: October 2026 ↗
Top 50 High-Quality Dividend Growth Stocks For October 2026 ↗
Notable healthcare headlines for the week: Novavax, Moderna and Becton Dickinson in focus ↗
SEC disclosures
Zoetis Inc. files 8-K: Material Event ↗
Recent filings
4 filing
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements · Regulation FD Disclosure
Items 5.02, 7.01, 9.01
Regulation FD Disclosure
Items 7.01, 9.01
4 filing
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements
Items 5.02, 9.01
Show 5 more recent filings
Financials
FY 2025 · USDSource
Source
Source
Source
balance sheet · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| ASSETS | ||||
| AssetsUSD | 15,467,000,000Source | 14,237,000,000Source | 14,286,000,000Source | 14,925,000,000Source |
| Property, Plant and Equipment, NetUSD | 3,681,000,000Source | 3,391,000,000Source | 3,204,000,000Source | 2,753,000,000Source |
| GoodwillUSD | 2,767,000,000Source | 2,724,000,000Source | 2,759,000,000Source | 2,746,000,000Source |
| Intangible Assets, Net (Excluding Goodwill)USD | 998,000,000Source | 1,127,000,000Source | 1,338,000,000Source | 1,380,000,000Source |
| Current assets: | ||||
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | 1,590,000,000Source | 1,316,000,000Source | 1,304,000,000Source | 1,215,000,000Source |
| Inventory, NetUSD | 2,430,000,000Source | 2,306,000,000Source | 2,564,000,000Source | 2,345,000,000Source |
| Assets, CurrentUSD | 6,768,000,000Source | 5,986,000,000Source | 6,343,000,000Source | 7,506,000,000Source |
| Operating Lease, Right-of-Use AssetUSD | 288,000,000Source | 219,000,000Source | 230,000,000Source | 220,000,000Source |
| Other Assets, NoncurrentUSD | 328,000,000Source | 250,000,000Source | 206,000,000Source | 147,000,000Source |
| LIABILITIES AND EQUITY | ||||
| LiabilitiesUSD | 12,136,000,000Source | 9,467,000,000Source | 9,295,000,000Source | 10,522,000,000Source |
| Stockholders’ equity: | ||||
| Common Stock, Value, IssuedUSD | 5,000,000Source | 5,000,000Source | 5,000,000Source | 5,000,000Source |
| Additional Paid in CapitalUSD | 1,101,000,000Source | 1,182,000,000Source | 1,133,000,000Source | 1,088,000,000Source |
| Retained Earnings (Accumulated Deficit)USD | 13,744,000,000Source | 11,968,000,000Source | 10,295,000,000Source | 8,668,000,000Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | -834,000,000Source | -940,000,000Source | -839,000,000Source | -817,000,000Source |
| Stockholders' Equity Attributable to ParentUSD | 3,331,000,000Source | 4,770,000,000Source | 4,997,000,000Source | 4,405,000,000Source |
| Liabilities and EquityUSD | 15,467,000,000Source | 14,237,000,000Source | 14,286,000,000Source | 14,925,000,000Source |
| Current liabilities: | ||||
| Liabilities, CurrentUSD | 2,235,000,000Source | 3,412,000,000Source | 1,889,000,000Source | 3,167,000,000Source |
| Operating Lease, Liability, CurrentUSD | 52,000,000Source | 51,000,000Source | 48,000,000Source | 43,000,000Source |
| Accounts Payable, CurrentUSD | 487,000,000Source | 433,000,000Source | 411,000,000Source | 405,000,000Source |
| Operating Lease, Liability, NoncurrentUSD | 196,000,000Source | 174,000,000Source | 188,000,000Source | 186,000,000Source |
| Deferred Income Tax Liabilities, NetUSD | 139,000,000Source | 167,000,000Source | 146,000,000Source | 142,000,000Source |
| Other Liabilities, NoncurrentUSD | 248,000,000Source | 222,000,000Source | 237,000,000Source | 217,000,000Source |
| Stockholders' Equity Attributable to Noncontrolling InterestUSD | 0Source | 0Source | -6,000,000Source | -2,000,000Source |
| Additional Financial Items | ||||
| Accrued Liabilities, CurrentUSD | 852,000,000Source | 746,000,000Source | 683,000,000Source | 682,000,000Source |
| Dividends Payable, CurrentUSD | 232,000,000Source | 224,000,000Source | 198,000,000Source | 174,000,000Source |
| Long-term Debt, Current MaturitiesUSD | 0Source | 1,350,000,000Source | 0Source | 1,350,000,000Source |
| Long-term Debt, Excluding Current MaturitiesUSD | 9,042,000,000Source | 5,220,000,000Source | 6,564,000,000Source | 6,552,000,000Source |
cash flow · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | 2,673,000,000Source | 2,496,000,000Source | 2,340,000,000Source | 2,111,000,000Source |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||
| Depreciation, Depletion and AmortizationUSD | 487,000,000Source | 497,000,000Source | 491,000,000Source | 465,000,000Source |
| Share-based Payment Arrangement, Noncash ExpenseUSD | 83,000,000Source | 74,000,000Source | 60,000,000Source | 62,000,000Source |
| Changes in operating assets and liabilities: | ||||
| Increase (Decrease) in Accounts ReceivableUSD | 236,000,000Source | 61,000,000Source | 102,000,000Source | 137,000,000Source |
| Increase (Decrease) in InventoriesUSD | 199,000,000Source | 40,000,000Source | 361,000,000Source | 486,000,000Source |
| Increase (Decrease) in Accounts PayableUSD | 46,000,000Source | 31,000,000Source | 13,000,000Source | -29,000,000Source |
| Deferred Income Tax Expense (Benefit)USD | -52,000,000Source | -338,000,000Source | -61,000,000Source | -286,000,000Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | 2,904,000,000Source | 2,953,000,000Source | 2,353,000,000Source | 1,912,000,000Source |
| Cash flows from investing activities: | ||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | -748,000,000Source | -315,000,000Source | -777,000,000Source | -883,000,000Source |
| Payments for (Proceeds from) Other Investing ActivitiesUSD | -1,000,000Source | 3,000,000Source | -2,000,000Source | 0Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | 621,000,000Source | 655,000,000Source | 732,000,000Source | 586,000,000Source |
| Cash flows from financing activities: | ||||
| Payments for Repurchase of Common StockUSD | 3,235,000,000Source | 1,858,000,000Source | 1,092,000,000Source | 1,594,000,000Source |
| Net Cash Provided by (Used in) Financing ActivitiesUSD | -1,870,000,000Source | -2,660,000,000Source | -3,109,000,000Source | -904,000,000Source |
| Proceeds from (Payments for) Other Financing ActivitiesUSD | -3,000,000Source | — | — | — |
| Repayments of Long-term DebtUSD | 1,350,000,000Source | 0Source | 1,350,000,000Source | 0Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | 325,000,000Source | -54,000,000Source | -1,540,000,000Source | 96,000,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | 2,312,000,000Source | 1,987,000,000Source | 2,041,000,000Source | 3,581,000,000Source |
| Supplemental disclosure of cash flow information: | ||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | 261,000,000Source | 274,000,000Source | 295,000,000Source | 242,000,000Source |
| Income Taxes Paid, NetUSD | 715,000,000Source | 892,000,000Source | 754,000,000Source | 638,000,000Source |
| Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | 39,000,000Source | -32,000,000Source | -7,000,000Source | -29,000,000Source |
| Additional Financial Items | ||||
| Amortization of Intangible AssetsUSD | 157,000,000Source | 170,000,000Source | 185,000,000Source | 193,000,000Source |
| Capitalized Computer Software, AmortizationUSD | 46,000,000Source | 61,000,000Source | 75,000,000Source | 69,000,000Source |
| Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to SettlementUSD | 0Source | -1,000,000Source | — | — |
| DepreciationUSD | 330,000,000Source | 327,000,000Source | 306,000,000Source | 272,000,000Source |
| Dividends Payable, CurrentUSD | 232,000,000Source | 224,000,000Source | 198,000,000Source | 174,000,000Source |
| Equity Method Investment, Other than Temporary ImpairmentUSD | — | — | — | 0Source |
| Foreign Currency Transaction Gain (Loss), before TaxUSD | -45,000,000Source | -50,000,000Source | -47,000,000Source | -62,000,000Source |
| Gain (Loss) on Disposition of AssetsUSD | — | — | 0Source | 0Source |
| Gain (Loss) on Disposition of BusinessUSD | -3,000,000Source | -23,000,000Source | 101,000,000Source | — |
| Gain (Loss) on Sale of Assets and Asset Impairment ChargesUSD | -3,000,000Source | -23,000,000Source | 118,000,000Source | 0Source |
| GoodwillUSD | 2,767,000,000Source | 2,724,000,000Source | 2,759,000,000Source | 2,746,000,000Source |
| Impairment of Intangible Assets (Excluding Goodwill)USD | 5,000,000Source | 15,000,000Source | 35,000,000Source | 39,000,000Source |
| Income Tax Expense (Benefit)USD | 687,000,000Source | 637,000,000Source | 596,000,000Source | 545,000,000Source |
| Inventory Write-downUSD | 68,000,000Source | 97,000,000Source | 115,000,000Source | 76,000,000Source |
| Net Income (Loss) Attributable to ParentUSD | 2,673,000,000Source | 2,486,000,000Source | 2,344,000,000Source | 2,114,000,000Source |
| Net Income (Loss) Attributable to Noncontrolling InterestUSD | 0Source | 10,000,000Source | -4,000,000Source | -3,000,000Source |
| Nonoperating Income (Expense)USD | 36,000,000Source | 19,000,000Source | 159,000,000Source | -40,000,000Source |
| Operating Lease, ExpenseUSD | 68,000,000Source | 59,000,000Source | 56,000,000Source | 51,000,000Source |
| Other Nonoperating Income (Expense)USD | -6,000,000Source | -4,000,000Source | -1,000,000Source | 14,000,000Source |
| Payments to Acquire InvestmentsUSD | 7,000,000Source | 5,000,000Source | 4,000,000Source | 9,000,000Source |
| Proceeds from (Payments to) Noncontrolling InterestsUSD | — | — | — | 0Source |
| Proceeds from Stock Options ExercisedUSD | 9,000,000Source | 20,000,000Source | 42,000,000Source | 15,000,000Source |
income statement · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Total RevenueUSD | 9,467,000,000Source | 9,256,000,000Source | 8,544,000,000Source | 8,080,000,000Source |
| Cost of RevenueUSD | 2,666,000,000Source | 2,719,000,000Source | 2,561,000,000Source | 2,454,000,000Source |
| Gross Profit (Calculated) · Derived | — | — | — | — |
| Selling, General and Administrative ExpenseUSD | 2,378,000,000Source | 2,318,000,000Source | 2,151,000,000Source | 2,009,000,000Source |
| Other Nonoperating Income (Expense)USD | -6,000,000Source | -4,000,000Source | -1,000,000Source | 14,000,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | 3,360,000,000Source | 3,133,000,000Source | 2,936,000,000Source | 2,656,000,000Source |
| Income Tax Expense (Benefit)USD | 687,000,000Source | 637,000,000Source | 596,000,000Source | 545,000,000Source |
| Net Income (Loss) Attributable to Noncontrolling InterestUSD | 0Source | 10,000,000Source | -4,000,000Source | -3,000,000Source |
| Net Income (Loss) Attributable to ParentUSD | 2,673,000,000Source | 2,486,000,000Source | 2,344,000,000Source | 2,114,000,000Source |
| Earnings Per Share, BasicUSD per share | 6.03Source | 5.47Source | 5.08Source | 4.51Source |
| Earnings Per Share, DilutedUSD per share | 6.02Source | 5.47Source | 5.07Source | 4.49Source |
| Weighted Average Number of Shares Outstanding, Basicshares | 443,443,000Source | 454,200,000Source | 461,172,000Source | 468,891,000Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | 443,835,000Source | 454,848,000Source | 462,269,000Source | 470,385,000Source |
| Additional Financial Items | ||||
| Amortization of Intangible AssetsUSD | 157,000,000Source | 170,000,000Source | 185,000,000Source | 193,000,000Source |
| Capitalized Computer Software, AmortizationUSD | 46,000,000Source | 61,000,000Source | 75,000,000Source | 69,000,000Source |
| Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to SettlementUSD | 0Source | -1,000,000Source | — | — |
| Foreign Currency Transaction Gain (Loss), before TaxUSD | -45,000,000Source | -50,000,000Source | -47,000,000Source | -62,000,000Source |
| Interest ExpenseUSD | 222,000,000Source | 225,000,000Source | 239,000,000Source | 221,000,000Source |
| Interest Income (Expense), Nonoperating, NetUSD | 93,000,000Source | 106,000,000Source | 105,000,000Source | 50,000,000Source |
| Nonoperating Income (Expense)USD | 36,000,000Source | 19,000,000Source | 159,000,000Source | -40,000,000Source |
| Operating Lease, ExpenseUSD | 68,000,000Source | 59,000,000Source | 56,000,000Source | 51,000,000Source |
Filing attachments
d166736dex991.htm · 8-K · 2026-08-06
EX-99.1 4 d166736dex991.htm EX-99.1 EX-99.1 Exhibit 99.1 Media Contacts: Investor Contacts: Jennifer Albano Steve Frank 1-862-399-0810 (o) 1-973-822-7141 (o) jennifer.albano@zoetis.com steve.frank@zoetis.com Laura Panza Nick Soonthornchai 1-973-975-5176 (o) 1-973-443-2792 (o) laura.panza@zoetis.com nick.soonthornchai@zoetis.com Zoetis Appoints Jay Saccaro as Chief Financial Officer an…
Read attachment ↗d35588dex41.htm · 8-K · 2025-12-18
EX-4.1 2 d35588dex41.htm EX-4.1 EX-4.1 Exhibit 4.1 ZOETIS INC. AND DEUTSCHE BANK TRUST COMPANY AMERICAS, as Trustee INDENTURE Dated as of December 18, 2025 0.25% Convertible Senior Notes due 2029 TABLE OF CONTENTS PAGE ARTICLE 1 DEFINITIONS Section 1.01. Defin…
Read attachment ↗d35588dex991.htm · 8-K · 2025-12-18
EX-99.1 5 d35588dex991.htm EX-99.1 EX-99.1 Exhibit 99.1 December 15, 2025 Zoetis Announces Proposed $1.75 Billion Convertible Senior Notes Offering Substantially All Net Proceeds Expected to Be Used to Repurchase Common Stock and for Capped Call Transactions PARSIPPANY, N.J. - (BUSINESS WIRE) - Zoetis Inc. (NYSE: ZTS) (the “Company” or “Zoetis”) today announced that, subject to market conditions, it intends to offer $1.75 billion aggregate principal amount of convertible senior notes du…
Read attachment ↗d35588dex992.htm · 8-K · 2025-12-18
EX-99.2 6 d35588dex992.htm EX-99.2 EX-99.2 Exhibit 99.2 December 16, 2025 Zoetis Announces Pricing of $1.75 Billion Convertible Senior Notes Offering Substantially All of Net Proceeds Expected to Be Used to Repurchase Approximately $1.6 Billion of Common Stock and for Capped Call Transactions PARSIPPANY, N.J. - (BUSINESS WIRE) - Zoetis Inc. (NYSE: ZTS) (the “Company” or “Zoetis”) today announced that it has priced its previously announced offering of $1.75 billion aggregate principal am…
Read attachment ↗d899078dex42.htm · 8-K · 2025-08-18
EX-4.2 3 d899078dex42.htm EX-4.2 EX-4.2 Exhibit 4.2 ZOETIS INC. SEVENTH SUPPLEMENTAL INDENTURE Dated as of August 18, 2025 4.150% Senior Notes due 2028 5.000% Senior Notes due 2035 (Seventh Supplemental Indenture to the Indenture Dated as of January 28, 2013) DEUTSCHE BANK TRUST COMPANY AMERICAS, as Trustee TABLE OF CONTENTS Page ARTICLE I DEFINITIONS …
Read attachment ↗d899078dex43.htm · 8-K · 2025-08-18
EX-4.3 4 d899078dex43.htm EX-4.3 EX-4.3 Exhibit 4.3 UNLESS THIS CERTIFICATE IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY, A NEW YORK CORPORATION (“DTC”), TO THE COMPANY OR ITS AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE OR PAYMENT, AND ANY CERTIFICATE ISSUED IS REGISTERED IN THE NAME OF CEDE & CO. OR IN SUCH OTHER NAME AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC (AND ANY PAYMENT IS MADE TO CEDE & CO. OR TO SUCH OTHER ENTITY AS IS REQUESTED BY AN …
Read attachment ↗